NCT03708432View on ClinicalTrials.gov

500mg Fulvestrant in HR+ MBC

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

July 15, 2017

Primary Completion Date

June 15, 2018

Study Completion Date

August 15, 2018

Conditions
Breast Cancer
Trial Locations (1)

200032

Fudan University Shanghai Cancer Center, Shanghai

All Listed Sponsors
lead

Fudan University

OTHER

NCT03708432 - 500mg Fulvestrant in HR+ MBC | Biotech Hunter | Biotech Hunter